[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
RedChip @RedChip on x 5592 followers
Created: 2025-07-21 14:30:10 UTC
🧪 Investor Spotlight: Exclusive Interview with Nexalin Technology $NXL CEO Mark White
@NexalinTech is advancing mental health treatment with its proprietary Deep Intracranial Frequency Stimulation (DIFSâ„¢), offering a non-invasive, drug-free solution to conditions like depression, PTSD, and systemic health issues.
Why This Matters to Investors:
- Breakthrough Tech: Gen-3 HALOâ„¢ Clarity headset targets deep brain structures: no drugs, no side effects.
- Clinical Momentum: Backed by 29+ trials and peer-reviewed research showing blood pressure reduction in depressive patients.
- Global Growth: Regulatory wins in China, Brazil, Oman; CE Mark in progress.
- Strategic Positioning: Supporting veteran-focused PTSD/TBI trials with @UCSanDiego; Industry Co-Chair of the National TBI Registry Coalition.
- Commercial Pathway: Scalable Virtual Clinic model integrates AI for at-home therapy, opening doors to the $537B global mental health market.
With a $X price target from Maxim and expanding IP portfolio, $NXL is emerging as a disruptor in neurohealth:
$NXL $VRTX $STIM $NMTC $LLY $AMGN
XXX engagements
Related Topics clarity mental health $nxl stocks technology investment